UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 895

Sortiert nach

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1162-1169

2018

Link zum Volltext

Verfügbarkeit prüfen

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.139-149

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe

Journal of viral hepatitis, 2018-03, Vol.25 (S1), p.6-17

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.86-94

2018

Link zum Volltext

Verfügbarkeit prüfen

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Journal of gastroenterology, 2012-05, Vol.47 (5), p.561-568

2012

Link zum Volltext

Verfügbarkeit prüfen

Editorial: dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2015-06, Vol.41 (11), p.1216-1217

Peck‐Radosavljevic, M.

2015

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (3), p.331-338

2014

Link zum Volltext

Verfügbarkeit prüfen

Letter: sustained virological response and liver healing – authors' reply

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (8), p.1173-1174

2017

Link zum Volltext

Verfügbarkeit prüfen

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients

Journal of viral hepatitis, 2012-11, Vol.19 (11), p.801-810

2012

Link zum Volltext

Verfügbarkeit prüfen

Carbon nanotube composites for thermal management

Applied physics letters, 2002-04, Vol.80 (15), p.2767-2769

2002

Link zum Volltext

Verfügbarkeit prüfen

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.83-91

2012

Link zum Volltext

Verfügbarkeit prüfen

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.707-718

2015

Link zum Volltext

Verfügbarkeit prüfen

Review article: coagulation disorders in chronic liver disease

Alimentary pharmacology & therapeutics, 2007-11, Vol.26 (s1), p.21-28

PECK‐RADOSAVLJEVIC, M.

2007

Link zum Volltext

Verfügbarkeit prüfen

Benchmarking nanotechnology for high-performance and low-power logic transistor applications

IEEE transactions on nanotechnology, 2005-03, Vol.4 (2), p.153-158

2005

Link zum Volltext
IEEE_Xplore

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Annals of oncology, 2016-05, Vol.27 (5), p.856-861

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Link zum Volltext

Verfügbarkeit prüfen

Flooding of Two Coal Open-Pit Mines in Serbia: The Aftermath of Global Climate Change

Journal of mining science, 2020, Vol.56 (1), p.79-83

2020

Link zum Volltext

Verfügbarkeit prüfen

240 MEASUREMENT OF LIVER STIFFNESS IN CHRONIC LIVER DISEASES VIA SHEAR WAVE ELASTOGRAPHY (AIXPLORER®): A VALID SUBSTITUTION FOR TRANSIENT ELASTOGRAPHY (FIBROSCAN®)?

Journal of hepatology, 2013-04, Vol.58, p.S103-S103

2013

Link zum Volltext

Verfügbarkeit prüfen

Atmospheric release of organic solvents due to hazardous events in the paints and varnishes industry

Hemijska industrija, 2023-01, Vol.77 (2), p.111-127

2023

Link zum Volltext

Verfügbarkeit prüfen

Reliability Assessment of Cross-Sector Model Diagnostics in the Case of Mining and Energy Complex after the Emergency Situation

Journal of mining science, 2022-08, Vol.58 (4), p.571-575

2022

Link zum Volltext

Verfügbarkeit prüfen

Tunneling versus thermionic emission in one-dimensional semiconductors

Physical review letters, 2004-01, Vol.92 (4), p.048301-048301, Article 048301

2004

Link zum Volltext

Verfügbarkeit prüfen

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma

British journal of cancer, 2018-05, Vol.118 (9), p.1162-1168

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 895

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(693)
Mit Volltextzugriff
(784)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(372)
Humans
(248)
Life Sciences & Biomedicine
(216)
Male
(169)
Female
(147)
Gastroenterology And Hepatology
(126)
Middle Aged
(125)
Adult
(118)
Physical Sciences
(100)
Technology
(91)
Biological And Medical Sciences
(86)
Aged
(78)
Medical Sciences
(73)
Gastroenterology & Hepatology
(68)
Engineering
(56)
Physics
(49)
Engineering, Electrical & Electronic
(43)
Chemistry
(42)
Animals
(41)
Treatment Outcome
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(183)
Srpski Arhiv Za Celokupno Lekarstvo
(26)
Alimentary Pharmacology & Therapeutics
(21)
Annals Of Oncology
(19)
Acta Chirurgica Iugoslavica
(15)
Vojnosanitetski Pregled
(15)
Ieee Electron Device Letters
(10)
Hemijska Industrija
(8)
Ptep
(8)
Tehnika
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Editorial: dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

Letter: sustained virological response and liver healing – authors' reply

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients

Carbon nanotube composites for thermal management

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Review article: coagulation disorders in chronic liver disease

Benchmarking nanotechnology for high-performance and low-power logic transistor applications

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Flooding of Two Coal Open-Pit Mines in Serbia: The Aftermath of Global Climate Change

240 MEASUREMENT OF LIVER STIFFNESS IN CHRONIC LIVER DISEASES VIA SHEAR WAVE ELASTOGRAPHY (AIXPLORER®): A VALID SUBSTITUTION FOR TRANSIENT ELASTOGRAPHY (FIBROSCAN®)?

Atmospheric release of organic solvents due to hazardous events in the paints and varnishes industry

Reliability Assessment of Cross-Sector Model Diagnostics in the Case of Mining and Energy Complex after the Emergency Situation

Tunneling versus thermionic emission in one-dimensional semiconductors

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma

Suchergebnisse filtern